DJIA 16,606.18 -274.18 -1.62%
NASDAQ 4,380.18 -82.72 -1.85%
S&P 500 1,932.85 -37.22 -1.89%
market minute promo

0.00 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

CADX 0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio -49.93
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS 0.13

Sector

Healthcare

Industry

Drugs

Cadence Pharmaceuticals, Inc. (CADX) Description

A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. Website: http://www.cadencepharm.com/

News & Commentary Rss Feed

Can Malllinckrodt Keep on Crushing Expectations?

FDA Approves Mallinckrodt's Xartemis XR - Analyst Blog

Recro Pharma IPO Could Be More Painful Than Expected

Wider-Than-Expected Q4 Loss at Cadence Pharma - Analyst Blog

Wider-Than-Expected Q4 Loss at Cadence Pharma - Analyst Blog

Patent Update from Mallinckrodt - Analyst Blog

Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog

This Week in Biotech: Three Strikes and You're Out!

The FDA and its advisory panel give a thumbs down to three experimental drugs, while buyout mania strikes the biotech sector.

Cadence: What To Do With The Proceeds And A Post Mortem On A Successful Investment

Everyone Wins in This Big Pharma Buyout

Here's one pharmaceutical buyout that the market loved on all sides.

Cadence Soars on Deal with Mallinckrodt - Analyst Blog

See More CADX News...

CADX's Top Competitors

CADX 0.00 (0.00%)
Current stock: CADX
JNJ $100.14 (-2.11%)
Current stock: JNJ
NVS $87.01 (-1.62%)
Current stock: NVS
RHHBY $36.34 (-1.33%)
Current stock: RHHBY